Shandong Buchang Pharmaceuticals(603858.SH): Application for clinical trials of attenuated chickenpox vaccine accepted

Shandong Buchang Pharmaceuticals (603858.SH) announced that its holding subsidiary Zhejiang Tianyuan Biopharmaceutical Co., Ltd.'s drug "Varicella Attenuated Live Vaccine" has received acceptance of its application for clinical trials by the National Medical Products Administration, and has received the "Acceptance Notice". The indications for Varicella Attenuated Live Vaccine: after vaccination with this vaccine, the body can produce immunity against Varicella-Zoster virus, and it is used for the prevention of chickenpox.